These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26010149)

  • 1. Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion.
    Chen JJ; Cai WY; Liu XW; Luo QC; Chen G; Huang WF; Li N; Cai JC
    PLoS One; 2015; 10(5):e0126890. PubMed ID: 26010149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer.
    Li Y; Gao Y; Xu Y; Ma H; Yang M
    Growth Factors; 2015; 33(4):267-74. PubMed ID: 26359764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNA-133b and its target gene FSCN1 in gastric cancer.
    Guo L; Bai H; Zou D; Hong T; Liu J; Huang J; He P; Zhou Q; He J
    J Exp Clin Cancer Res; 2014 Nov; 33(1):99. PubMed ID: 25433493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
    Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
    Zhang Y; Yang X; Wu H; Zhou W; Liu Z
    Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
    Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
    Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
    Lai C; Chen Z; Li R
    Mol Med Rep; 2015 Jul; 12(1):1473-8. PubMed ID: 25815687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
    Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
    Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer.
    Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y
    Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
    Xu W; Chang J; Du X; Hou J
    Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.
    Liu Y; Hong W; Zhou C; Jiang Z; Wang G; Wei G; Li X
    Oncol Rep; 2017 May; 37(5):2593-2602. PubMed ID: 28393215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression.
    Xue M; Zhao L; Yang F; Li Z; Li G
    Mol Med Rep; 2016 Jan; 13(1):1033-9. PubMed ID: 26647829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microRNA-367 inhibits the invasion and metastasis of gastric cancer by directly repressing Rab23.
    Bin Z; Dedong H; Xiangjie F; Hongwei X; Qinghui Y
    Genet Test Mol Biomarkers; 2015 Feb; 19(2):69-74. PubMed ID: 25489984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151.
    Wang X; Yu H; Lu X; Zhang P; Wang M; Hu Y
    Biochem Biophys Res Commun; 2014 Feb; 445(1):175-9. PubMed ID: 24495805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.
    Li X; Zhang Y; Zhang H; Liu X; Gong T; Li M; Sun L; Ji G; Shi Y; Han Z; Han S; Nie Y; Chen X; Zhao Q; Ding J; Wu K; Daiming F
    Mol Cancer Res; 2011 Jul; 9(7):824-33. PubMed ID: 21628394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.